Endogenous TNF alpha orchestrates the trafficking of neutrophils into and within lymphatic vessels during acute inflammation by Arokiasamy, S et al.
Endogenous TNF orchestrates the trafficking of neutrophils into and within
lymphatic vessels during acute inflammation






© The Author(s) 2017
 
 





Information about this research object was correct at the time of download; we occasionally
make corrections to records, please therefore check the published record when citing. For
more information contact scholarlycommunications@qmul.ac.uk
Arokiasamy et al. 
1 
 
Endogenous TNF orchestrates the trafficking of neutrophils into and within lymphatic vessels 
during acute inflammation 
 
Samantha Arokiasamy 1,2, Christian Zakian 1, Jessica Dilliway 1, Wen Wang 2#, Sussan Nourshargh 1# 
& Mathieu-Benoit Voisin 1*. 
 
1 William Harvey Research Institute, Barts and the London School of Medicine and Dentistry; and 2 
School of Engineering and Materials Science; Queen Mary University of London, London, UK. # Joint-
second last authors. 
 
* Corresponding author: Mathieu-Benoit Voisin, William Harvey Research Institute, Barts and The 
London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, 
London EC1M 6BQ, United Kingdom. 
Phone: +44 2078828238 Fax: +44 20788282527 
E-mail: m.b.voisin@qmul.ac.uk  
 
TNF drives neutrophil trafficking into lymphatics 
  




Neutrophils are recognised to play a pivotal role at the interface between innate and acquired immunities 
following their recruitment to inflamed tissues and lymphoid organs. While neutrophil trafficking 
through blood vessels has been extensively studied, the molecular mechanisms regulating their 
migration into the lymphatic system are still poorly understood. Here, we have analysed neutrophil-
lymphatic vessel interactions in real time and in vivo using intravital confocal microscopy applied to 
inflamed cremaster muscles. We show that antigen sensitisation of the tissues induces a rapid but 
transient entry of tissue-infiltrated neutrophils into lymphatic vessels and subsequent crawling along 
the luminal side of the lymphatic endothelium. Interestingly, using mice deficient in both TNF receptors 
p55 and p75, chimeric animals and anti-TNFα antibody blockade we demonstrate that tissue-release of 
TNFα governs both neutrophil migration through the lymphatic endothelium and luminal crawling. 
Mechanistically, we show that TNFα primes directly the neutrophils to enter the lymphatic vessels in a 
strictly CCR7-dependent manner; and induces ICAM-1 up-regulation on lymphatic vessels, allowing 
neutrophils to crawl along the lumen of the lymphatic endothelium in an ICAM-1/MAC-1-dependent 
manner. Collectively, our findings demonstrate a new role for TNFα as a key regulator of neutrophil 
trafficking into and within lymphatic system in vivo. 
  




Neutrophils have classically been considered to be prototypical short-lived and terminally differentiated 
phagocytes involved in innate immune responses following their rapid recruitment at site of infections 
and acute inflammation 1-3. Compared to other leukocytes, their life span does not exceed 1-5 days in 
the circulation 4 though several cytokines such as GM-CSF 5,6, bacteria-derived products 7, hypoxia 8 or 
their migration through the blood vessel walls 9,10 can significantly expand their life expectancy both in 
vivo and in vitro. Until recently, neutrophils were thought to end their life in inflamed tissues by 
apoptosis before being engulfed by other phagocytic cells to limit and resolve inflammation 11,12. 
However, 45 years ago, neutrophils were detected within the lymphatic system 13. It was suggested that 
this response represented a way for neutrophils to recirculate back into the blood vasculature; and their 
role in the lymphatic system was thus largely neglected. Recently, however, accumulating evidence has 
shown that the role of neutrophils spans beyond the basic but fundamental immunological processes of 
innate immunity 14. Specifically, neutrophils can actively participate in the regulation of adaptive 
immunity following exposure to pathogens and antigens sensitisation 14-17 by means of antigen 
presentation or cytokine release for stimulating T- and B-lymphocytes 18-22 as well as DCs 23. 
 
While their role in regulating adaptive immunity is now well documented, few studies have investigated 
the mechanisms associated with neutrophil migration into the lymphatic vasculature. A clue to this 
phenomenon was first suggested through neutrophil localisation in the draining lymph nodes (dLNs) 
within the capsula and carrying fluorescently-labelled antigens or pathogens from the sites of antigen-
sensitisation or infection 15,16,24. These results indicated their provenance from tissue-associated 
lymphatic capillaries via afferent lymphatic vessels. Furthermore, antigen-bearing neutrophils 
trafficking to dLNs preceded the influx of other professional antigen-presenting cells such as DCs and 
macrophages 25; and blocking their entry or depleting mice in circulating neutrophils reduced T-cell 
proliferation in vivo 26, confirming a critical role for these leukocyte in the development of adequate 
adaptive immune responses. Recently, neutrophils have also been shown to migrate directly into the 
LNs from the blood circulation via high endothelial venules (HEVs). The molecular signature of these 
migratory responses is however unclear; and there are currently conflicting data in the literature 
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regarding the chemotaxis pathway involved in this phenomenon. A role for CCR7 in neutrophil 
migration into the LNs of immunised animals was first demonstrated 27, while other studies have 
implicated the CXCR4:CXCL12 axis and Sphingosine-1-Phosphate 26,28. Leukocyte integrins and 
selectins have also been implicated in neutrophil trafficking to LNs 28, though their exact contribution 
to cell migration through afferent lymphatic vessels near sites of inflammation in vivo is still unclear.  
 
Despite these seminal but conflicting reports, further investigations are required to fully understand the 
mechanisms associated with this response. Here we provide evidence for the involvement of TNFα in 
the trafficking of neutrophils into but also within the lymphatic vasculature in vivo. Specifically, using 
a mouse model of antigen sensitisation and cytokine-induced inflammation of the cremaster muscle, we 
demonstrate that TNFα orchestrates both neutrophil migration into lymphatic vessels in a CCR7-
dependent manner and their subsequent crawling along the lymphatic endothelium in an ICAM-
1/MAC-1-dependent manner. Collectively, the present findings identify a previously unknown role for 
TNFα in orchestrating sequential interactions of neutrophils with tissue-associated lymphatic vessels 
during the acute inflammatory response of antigen sensitisation; and highlight TNFα as a potential 
target for the manipulation of neutrophil regulation of adaptive immune responses within the lymphatic 
system. 
  





TNFα promotes neutrophil migration into lymphatic vessels of murine cremaster muscles. 
Neutrophil migration into the lymphatic system has been described in models of infections and 
immunisation sensitisation 15,16,24,27, but the mechanisms associated with this response are not fully 
understood and somewhat controversial. For this purpose, we studied neutrophil-lymphatic vessel 
interactions in vivo using a mouse model of cremaster muscle inflammation, allowing the direct 
visualisation in 3- and 4- dimensions of cell-cell interactions by high-resolution confocal microscopy. 
Whole-mount cremaster tissues of mice immunostained for LYVE-1 and PECAM-1/VE-Cadherin, 
showed the presence of a unidirectional network of lymphatic vessels with characteristic blind-ended 
lymphatic capillaries and collecting afferent vessels made up of oak-leaf shaped lymphatic endothelial 
cells (LEC) (Supplementary Figure S1) as previously described in other tissues 29,30. Following tissue-
stimulation with exogenous TNFα, neutrophils were rapidly detected in the lumen of lymphatic vessels 
(Figure 1a). Detailed analysis of TNFα-stimulated tissues demonstrated a time-dependent migration of 
neutrophils out of blood vessels post TNFα-administration (Figure 1b). This response was associated 
with a rapid and transient migration of neutrophils into lymphatic vessels at 8hrs post-inflammation 
(Figure 1c), as well as into the cremaster muscle draining lymph nodes (dLNs) (Figure 1d). We then 
went on to analyse in vivo and in real time the dynamics of neutrophil-lymphatic vessel interactions in 
the cremaster muscle of the neutrophil reporter LysM-GFP mice upon TNFα-stimulation. For this 
purpose, in vivo fluorescent-immunostaining with non-blocking anti-PECAM-1 and/or a non-inhibitory 
dose of anti-LYVE-1 mAbs was applied to the tissues to visualise endothelial cells and lymphatic 
vessels, respectively, to allow the tracking of GFPhigh neutrophils responses into the lymphatic 
vasculature by intravital confocal microscopy. With this technique, neutrophils were seen to migrate 
rapidly (4.5±0.6min) through LECs (Figure 1e & Videos 1/2). Furthermore, we observed that following 
their entry into the lymphatic vessels, intravasated neutrophils were firmly attached to the LECs and 
were crawling along the luminal surface of the lymphatic endothelium. (Figure 1f & Video 3). Analysis 
of neutrophil crawling dynamics showed that 63.7±5.7% of the neutrophils crawl along the luminal 
surface of the LECs in the direction of the lymphatic flow at a speed of 4.3±0.2µm/min; while the few 
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neutrophils venturing against the natural direction of lymphatic flow showed a reduced crawling speed, 
displacement length and straightness (Figures 1g-j).  
 
Collectively, these results demonstrate that the cytokine TNFα induces the migration of neutrophils into 
lymphatic vessels and promotes their crawling along the luminal aspect of LECs in vivo. 
 
 
TNFα controls the entry of neutrophils into lymphatic vessels following antigen sensitisation. 
Having observed the efficacy of exogenous TNFα in inducing neutrophil migration into lymphatic 
vessels, we next investigated the potential role of endogenous TNFα in this response in a model of 
antigen sensitisation. For this purpose, we first analysed the migration response of neutrophils into the 
dLNs of mice subjected to skin inflammation with an emulsion of an antigen in Complete Freund’s 
Adjuvant (CFA+Ag), reproducing the classical immunisation procedure. Injection of CFA+Ag induced 
a time-dependent increase in the number of neutrophils in the dLNs (namely inguinal and lumbar LNs) 
as compared to non-dLN (i.e. axillary LNs) (Figure 2a). This model was then extended to the cremaster 
muscle to look at neutrophil-lymphatic vessel interactions in vivo. Quantification of neutrophil 
migration responses through blood and into lymphatic vasculatures showed a time-dependent increase 
in the number of neutrophils (Figures 2b-c), both peaking at 8hrs post-inflammation. This response 
was associated with an increase in neutrophil infiltration of the dLNs of the cremaster muscles but not 
of non-dLNs (Figure 2d). Because of the low incidence of cells (less than 1% of total LN-infiltrated 
leukocytes as observed by flow cytometry) and to exclude from the analysis the increase of circulating 
neutrophils due to CFA+Ag-induced neutrophilia (Figure S2), we performed detailed analysis of 
whole-mount dLNs immunostained for HEVs (blood vasculature), LYVE-1 (lymphatic vasculature) 
and MRP14 (neutrophils) by confocal microscopy. We showed that ~60% of neutrophils (Figure 2e) 
at 8hrs post-inflammation were within LYVE-1+ vessels. At 16hrs post-inflammation, only ~25% of 
the neutrophils were found in this location while ~58% of the cells were found in the LN stroma. 
Overall, only a minority of the neutrophils were found within the HEVs at these time-points. These data 
suggest that the early and rapid migration of neutrophils into dLNs may occur via afferent lymphatics. 
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Interestingly, CFA+Ag-stimulation of cremaster muscles induced a rapid release of TNFα in tissues 
from 8hrs onward and reaching the maximum response at 16hrs post-inflammation (Figure 3a). 
Furthermore, mice depleted in resident phagocytes (i.e. macrophages) following the local delivery of 
clodronate liposomes exhibited a reduction in TNFα release as compared to control liposome-treated 
animals (Figure 3b). To investigate the functional role of endogenous TNFα during CFA+Ag-
inflammation, neutrophil migration responses were quantified in mice deficient in both TNFR p55 and 
P75 receptors (TNFRdKO mice). These studies showed that while neutrophil extravasation into tissues 
was similar between WT and TNFRdbKO mice (Supplementary Figure S3a & Figure 3c), neutrophil 
migration into cremaster lymphatic vessels was reduced by 84% and 75% in KO animals at 8hrs and 
16hrs post-inflammation, respectively (Supplementary Figure S3b & Figure 3d). This response was 
associated with a reduced (~64%) neutrophil-infiltration of the dLNs (Figure 3e). In order to address 
the origin of cell type responding to the endogenous release of TNFα during inflammation and 
promoting neutrophil migration into the lymphatic vessels, we generated chimeric animals. For this 
purpose, lethally irradiated WT mice were reconstituted with bone marrow hematopoietic cells from 
either WT or TNFRdbKO animals before being subjected to antigen sensitisation (Supplementary 
Figure S4). Similarly to full TNRFdbKO mice, the neutrophil migration response into the lymphatic 
system was impaired in chimeric animals exhibiting WT vasculature and tissue-resident cells but 
neutrophils deficient in TNFRs, as compared to the control group; while extravasation through blood 
vessels was not affected (Figures 3f-h). 
 
Together these data demonstrate that endogenous TNFα directly primes the leukocytes to trigger the 
migration of neutrophils into tissue-associated lymphatic vessels post-antigen sensitisation in vivo. 
 
 
TNFα promotes CCR7-dependent migration of neutrophils into lymphatic vessels in vivo. 
Having identified a role for endogenous TNFα in controlling the entry of neutrophils into lymphatic 
vessels, we then went on to decipher the molecular mechanism involved and more specifically which 
chemokine/chemokine axis was associated with this response. We first investigated the role of CXCL1 
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on neutrophil trafficking into the lymphatic vasculature in vivo, as the human equivalent of this 
chemokine has been shown recently to promote neutrophil migration through a monolayer of lymphatic 
endothelial cells in vitro 31. However, local delivery of anti-CXCL1 blocking antibody did not affect 
the migration of neutrophil into the lymphatic vasculature of inflamed cremaster muscles in vivo 
(Supplementary Figures S5a-c). We then went on to analyse the role of CXCR4:CXCL12 axis shown 
previously to promote the entry of neutrophils into the lymphatic system in different inflammatory 
models 26,28. Similarly to CXCL1-blockade, local injection the CXCR4 specific inhibitor AMD3100 did 
not significantly influenced the capacity of neutrophils to migrate into the lymphatic vessels upon 
antigen sensitisation (Supplementary Figures S5d-f). In fact, analysis of blood circulating leukocytes 
by flow cytometry showed that while CFA+Ag-inflammation induced neutrophilia in both AMD3100- 
and vehicle-treated mice as compared to unstimulated animals (Figure S5g), CXCR4 surface 
expression was down-regulated with the inflammation (Figure S5h). Collectively, these results suggest 
that the chemotactic axes CXCL12:CXCR4 and CXCL1:CXCR1/2 do not play a significant role in 
neutrophil recruitment into the lymphatic vessels during the acute inflammatory response as induced by 
CFA+Ag in vivo. 
 
Finally, the potential involvement of the CCL21/CCR7 axis, widely linked with DC/T-cell migration 
into the lymphatic system 32 was then explored in our model despite conflicting studies regarding the 
role of CCR7 in neutrophils 26,27. The expression of CCR7 on blood-born, cremaster tissue-infiltrated 
and dLN-infiltrated neutrophils, was first examined by flow cytometry post CFA+Ag-induced 
inflammation (Figure 4a). WT blood neutrophils did not express CCR7 on their surface, we could 
detect intracellular stores of the molecule. Interestingly, neutrophils isolated from CFA+Ag-inflamed 
cremaster muscles showed a small but significant expression of CCR7 on their cell surface. 
Interestingly, this upregulation of CCR7 on tissue-infiltrated neutrophils was absent in TNFRdbKO as 
compared to WT littermates (Figure 4b). Furthermore, stimulation of mouse blood neutrophils with 
low concentrations of TNFα in vitro induced the surface expression of CCR7 (Supplementary Figure 
S6). Having found that tissue-infiltrated neutrophils up-regulate CCR7 on their cell surface, we 
hypothesised that this chemokine receptor may mediate the migration of neutrophils through lymphatic 
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vessels of the cremaster muscles. To address this, we initially looked at neutrophil migration responses 
in both WT and CCR7KO animals following TNFα stimulation. Interestingly, while neutrophil 
extravasation into tissues was not affected (Figure 4c), trafficking of neutrophils into cremaster muscle 
lymphatic vessels was completely inhibited in CCR7KO animals as compared to WT animals (~97% 
suppression) (Figure 4d). With regard to their infiltration into cremaster dLNs, TNFα induced an 
increase of neutrophils compared to control group (Figure 4e). However, in TNFα-stimulated CCR7KO 
mice, the number of neutrophils into the dLNs was comparable to the levels found in unstimulated 
animals. Similarly, while neutrophil extravasation in response to CFA+Ag was unaffected in CCR7KO 
mice (Supplementary Figure S3a & Figure 4f), neutrophil migration into lymphatic vessels was 
suppressed by ~86% and 75% in CCR7KO animals as compared to WT mice in this model at 8 and 
16hrs post-inflammation, respectively (Supplementary Figure S3b & Figure 4g). Furthermore, and 
in contrast to WT animals, the level of dLN-infiltrated neutrophils was not increased in CCR7KO mice 
after stimulation with CFA+Ag (Figure 4h). Of note, CCR7KO animals exhibited ~25 times more LN-
infiltrated neutrophils than WT mice in unstimulated conditions, a response related to a higher 
expression of CXCL12 in the LNs of CCR7KO animals as compared to WT mice (Supplementary 
Figure S7), suggesting a compensatory mechanism during the development of these GM mice. 
Furthermore, using the specific inhibitor of CXCR4 (receptor for CXCL12), AMD3100, we could 
reduce the number of neutrophils present in the LNs of CCR7KO animals (Supplementary Figure S7). 
To overcome the abnormal trafficking of neutrophils into the LNs in CCR7KO animals, we generated 
chimeric animals by injecting lethally irradiated WT mice with bone marrow cells from CCR7KO 
animals (or WT bone marrow cells as control). This resulted in the generation of animals exhibiting 
CCR7KO circulating neutrophils in a WT environment. Similarly to a full KO, chimeric exhibiting 
CCR7KO neutrophils showed a reduced migration of these leukocytes  (~76% reduction) into the 
lymphatic vasculature of the cremaster muscle upon antigen challenge while neutrophil recruitment 
from the blood into the tissue was similar to the control chimeric group (Figures 4i-j). Interestingly, 
CCR7KO-neutrophil chimeric animals also showed a reduced number of neutrophils infiltrating the 
dLNs (~62%) as compared to control littermate (Figure 4k); suggesting that neutrophils from CCR7KO 
donor cells are not able to migrate efficiently into the LNs of the WT recipient mice. 




Collectively, these data demonstrate that TNFα mediates CCR7-dependent migration of neutrophils 
into afferent lymphatic vessels. 
 
 
TNFα also controls the crawling of neutrophils along the luminal side of afferent lymphatic 
endothelium.  
Using intravital confocal microscopy we observed that TNFα-induced inflammation results in 
neutrophils crawling along the lymphatic endothelium (Figure 1f & Video 3). Similarly to TNFα-
stimulation, CFA+Ag led to neutrophil crawling along the lumen of LECs (Video 4). The majority of 
these leukocytes moved in the direction towards collecting lymphatic vessels/lymph flow (67.8±3.8%) 
at a speed of 5.8±0.2µm/min and with a straightness index of 0.40±0.04; while cells going against lymph 
flow direction had reduced speed and directionality of movement (Figure 5 & Video 5). Interestingly, 
the favoured directionality of neutrophils was associated with the establishment of a gradient of CCL21 
within the lymphatic vessel in the direction of the lymph flow during inflammation (Supplementary 
Figure S8). Furthermore, when an anti-TNFα blocking antibody was injected 4hrs post-CFA+Ag-
stimulation, the few neutrophils present within the lymphatic lumen completely lost their directional 
motility. Cells did not show any preferential direction of migration but exhibited instead a meandering 
crawling path associated with reduced speed and directionality as compared to isotype control treated 
animals. 
 
These data suggest that, during the acute phase of the inflammatory response to CFA+Ag, TNFα 
controls the directional crawling of neutrophils within the lymphatic vessels. 
 
 
ICAM-1 mediates TNFα-induced neutrophil crawling within lymphatic vessels. 
To investigate the molecular mechanisms of neutrophil intraluminal crawling in lymphatics, we studied 
the role of ICAM-1, an adhesion molecule known to support neutrophil crawling along both the luminal 
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33 and abluminal 34 surfaces of blood vessels. In initial studies we analysed ICAM-1 expression on 
cremaster lymphatics under basal and inflamed conditions by immunostaining. Both TNFα and 
CFA+Ag induced an up-regulation of ICAM-1 expression in vivo as compared to vehicle-treated 
animals (Figures 6a/b). Interestingly, when CFA+Ag-stimulated cremaster muscles were pre-treated 
with an anti- TNFα blocking antibody, the expression of ICAM-1 on lymphatics was reduced as 
compared to the control antibody-treated group (Figure 6c). To further assess the role of ICAM-1 in 
neutrophil crawling behaviour within the lymphatic vessels, we performed functional assays using local 
administration (injected 4.5hrs post-inflammation) of functional blocking antibodies against ICAM-1 
or its leukocyte binding partner, the integrin MAC-1 in CFA+Ag-stimulated cremaster muscles of 
LysM-GFP mice. Both anti–ICAM-1 and anti–MAC-1 mAbs impaired neutrophil intraluminal crawling 
within lymphatics as compared to an isotype control Ab (Figures 7a/b and Video6/7/8). Specifically, 
blocking ICAM-1 or MAC-1 resulted in a ~50% reduction in the speed of crawling, displacement length 
and straightness within the luminal side of lymphatic endothelium (Figures 7c/d/e). In contrast, 
interstitial migration was not affected by these treatments. Overall, while the time and route of delivery 
of the blocking antibodies had no effect on leukocyte extravasation from blood vessels and migration 
into lymphatic vessels, respectively (Figures 7f/g), blocking the intraluminal crawling of neutrophils 
within lymphatic vessels resulted in a reduction in the number of neutrophils infiltrating the dLNs 
(Figures 7h). 
 
Collectively, the present findings identify ICAM-1 as an adhesion molecule that mediates neutrophil 
crawling along the lymphatic endothelium and identify TNFα as a key regulator of neutrophil 
directional motility within lymphatic vessels in vivo. 
  




It is now well established that neutrophils contribute to the shaping of the adaptive immunity against 
many foreign antigens or infectious agents following their rapid migration into the lymphatic system 
15,19,35. However, the mechanisms of his migratory behaviour are poorly understood. In the present study 
we have identified a previously unknown role for endogenous TNFα in orchestrating neutrophil 
trafficking into and within the lymphatic vasculature of inflamed tissues in vivo. Specifically, we 
demonstrate that in a mouse model of antigen sensitisation, endogenous TNFα directly instructs the 
neutrophils to migrate into the lymphatic vessels in a strictly CCR7-dependent manner and also induces 
their subsequent directional crawling along the lumen of the lymphatic endothelium as mediated by 
ICAM-1 up-regulation on lymphatic endothelial cells. The new mechanisms of TNFα action on 
neutrophil-lymphatic interactions are summarised in Figure 8. 
 
In initial studies aimed at investigating TNFα-induced neutrophil trafficking into extravascular tissues, 
we noted that tissue infiltrated neutrophils could rapidly migrate into lymphatic vessels. These studies 
were then extended to a model of antigen sensitisation characterised by the generation of endogenous 
TNFα. This reaction was also associated with rapid neutrophil migration into lymphatic vessels, a 
response that was impaired in mice deficient in both TNF receptors p55 and p75. Interestingly, TNFα 
did not appear to mediate neutrophil extravasation from blood vessels into tissues, indicating a specific 
role for TNFα in driving neutrophil motility into lymphatic vessels but not through blood vasculature. 
Furthermore, using chimeric animals we showed that TNFα acts directly of the leukocytes to induce 
this neutrophil migration response. 
 
In the present study, we clearly demonstrated that the TNFα-driven migration of neutrophils into 
lymphatic vessels is strictly CCR7-dependent. The role of CCR7 in neutrophil recruitment to the 
lymphatic system was demonstrated both in a mouse model of intradermal immunisation and in human 
neutrophils by Beauvillain et al. 27 In accordance with their study, we only detected intracellular stores 
of CCR7 in murine blood neutrophils, but not on their cell surface. However our results shows that 
neutrophils recruited into inflamed tissues up-regulated CCR7 on their surface as compared to blood 
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circulating cells. A study by Eruslanov et al. have shown similar up-regulation of CCR7 on human 
neutrophils in a tumour model 36, though the mechanism and physiological consequences of this 
response in human is still unclear. Our current data suggests priming of neutrophils for enhanced 
chemokine receptor expression. While GM-CSF and IL-17 have been shown to prime human 
neutrophils to migrate toward the chemokines CCL21 and CCL19 in vitro 27, we did not detect the 
generation of these cytokines in the inflamed cremaster muscles at any time-point analysed 
(Supplementary Figure S9). However, TNFRdbKO tissue-infiltrated neutrophils did not show an 
increase in CCR7 expression on neutrophils in vivo; while low concentrations of TNFα promoted the 
surface expression of CCR7 on murine blood neutrophils in vitro. Altogether these data suggest a 
predominant role of TNFα in this response and may highlight the importance of the origin of the cells 
analysed (e.g. bone marrow vs blood, tissue-infiltrated vs naïve cells, murine vs. human leukocytes). 
Interestingly, we observed that CCR7KO animals exhibited a high basal level of neutrophils within the 
LNs of naïve animals as compared to WT mice; and inflammation of the cremaster muscles with TNFα 
or following antigen sensitisation did not increase further the number of neutrophils found in the LNs. 
This abnormal trafficking of neutrophils into the LNs of these mice could be related to a higher 
expression of CXCL12 in naïve CCR7KO dLNs as compared to WT dLNs. CXCR4 expression was 
similar in both genotypes, however, CXCR4 antagonist treatment reduced significantly the number of 
these leukocytes infiltrating CCR7KO dLNs, while their migration into the afferent lymphatics was not 
affected (Supplementary Figure S7). These data support the hypothesis that CXCR4 signalling 
contributes to neutrophil homing in LN through HEV 28.  
 
Since the role for CCR7 in neutrophils trafficking has been contentious to date, we have also 
investigated other chemokine/chemokine receptor axes in this phenomenon, such as the 
CXCL12/CXCR4 axis. This axis was shown recently to be involved in neutrophil trafficking to the 
lymphatic system in a model of bacterial infection with S. aureus 26. However, our data demonstrate 
that CXCR4 blockade did not significantly inhibit neutrophil migration into cremaster lymphatic vessels 
upon CFA+Ag-stimulation (Supplementary Figure S5). Such differences between their study and ours 
could be related to the model and inflammatory pathway involved: S. aureus infection may 
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preferentially activates the toll-like receptor 2 (TLR2) pathway in vivo 37-40. Recently, TLR2 was shown 
to be associated with CXCR4 in lipid rafts of monocytes to induce signalling 41, a response not yet 
investigated for neutrophils. In contrast, the TLR4 pathway is involved in M. tuberculosis infections, 
LPS or CFA stimulation 42; and TLR4 ligands can induce TNFα release more rapidly than TLR2 
agonists in vitro 43. Finally, both TNFα 44 and TLR4 activation 45 have been shown to down-regulate 
the expression of CXCR4 on neutrophils, rendering them less responsive to CXCL12 stimulation. This 
supports our observation of a similar down-regulation of CXCR4 expression by neutrophils in our 
inflammatory model (Supplementary Figure S5). Furthermore, CXCR4 is highly expressed on a 
subclass of ageing neutrophils rather than healthy mature cells 46. Altogether, these observations may 
indicate that different sub-populations of neutrophils or their pathway of activation might be important 
for the molecular axis used for their migration into the lymphatic system. 
Another study has shown that the potent neutrophil-chemoattractant CXCL8 was up-regulated in TNFα-
stimulated human dermal endothelial cells in vitro; and promotes neutrophil migration through a 
monolayer of human LECs 31. In the mouse system, LECs isolated from mouse skin showed an 
upregulation of CXCL1 gene upon inflammation 47. However, our in vivo model of TNFα-induced 
neutrophil trafficking into lymphatic vessels, clearly indicated the predominant role of CCR7 in this 
phenomenon. Furthermore local treatment with an anti-CXCL1 blocking mAb did not affect the 
capacity of neutrophils to enter the lymphatic system upon inflammation in vivo. These data highlight 
differences between in vivo and in vitro models. Indeed, several studies pointed to the importance of 
the microenvironment for the LECs to retain their specific lymphatic characteristic that are lost in 
culture such as the capacity to generate CCL21 48,49. Similarly to a mouse model of contact 
hypersensitivity 47, we did not observed a change in total CCL21 expression between naïve and inflamed 
animals (Supplementary Figure S8). We however noticed that lymphatic vessels exhibited higher 
expression of CCL21 as compared to the interstitial tissue with the establishment of a gradient that 
could direct the neutrophils toward the vessels in vivo. The formation of a gradient of CCL21 driving 
the migration of DCs within the LNs has been recently reported in the literature 50. 
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Having identified TNFα as a key signal for promoting neutrophil trafficking to the lymphatic vessels, 
the potential involvement of this cytokine in mediating other neutrophil-lymphatic vessel interactions 
was investigated. TNFα is the prototypical pro-inflammatory cytokine playing a key role in many 
immune responses such as cell recruitment and leukocyte activation. It is also involved in numerous 
pathological conditions and autoimmune disorders such as rheumatoid arthritis, lupus, psoriasis and 
atherosclerosis and there is now considerable evidence for successful use of TNFα blockers for the 
treatment of certain chronic inflammatory conditions. However, anti- TNFα therapy is associated with 
a heightened risk of serious infections and poor vaccination responses in patients 51. Furthermore, the 
mechanism through which these drugs work is not fully known; though suppressing leukocyte 
recruitment and activation is considered to be a principle mode of action 52. In our acute model of 
cremasteric inflammation however, we neither genetic deficiency for TNFα signalling nor antibody 
blockade inhibited neutrophil recruitment to the tissue, suggesting different roles for TNFα in acute vs 
chronic inflammation. During physiological conditions, TNFα can prime blood vascular endothelial 
cells (BECs) to present both adhesion molecules and chemoattractants in order to induce leukocyte 
migration. Specifically, TNFα has been shown to up-regulate ICAM-1 expression on BECs both in vivo 
and in vitro, an adhesion molecule essential for neutrophil directional crawling during their recruitment 
through blood vessels 33,34. Lymphatic endothelial cells (LECs) express very low levels of ICAM-1 in 
uninflamed condition, but can up-regulate this molecule upon TNFα-stimulation in both humans 53,54 
and mice (Figure 6). The exact role of ICAM-1 in leukocyte migration into the lymphatic system is 
however controversial: in vitro antibody blockade inhibits both adhesion and transmigration responses 
of DCs through cultured human LECs 53, and in vivo ICAM-1 have been reported to mediate crawling 
of DCs along the lymphatic endothelium 55. In contrast, DC interstitial migration was not affected in 
mice exhibiting leukocyte-specific deletion of ICAM-1-ligand integrins 56. In the present study, we have 
observed that neutrophils crawl along the luminal surface of the lymphatic endothelium following a 
local inflammatory stimulus. This response was associated with a formation of a gradient of CCL21 
within the vessel (Supplementary Figure S8e). This gradient could explain why the majority of 
neutrophils crawl along in the direction of the lymphatic flow. Interestingly, Russo et al., have recently 
demonstrated that in vitro, murine LECs generate a gradient of CCL21 when exposed to low sheer stress 
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and that this gradient was responsible for the directionality of crawling of DCs 57. In our model, the 
neutrophil crawling response (as well as ICAM-1 upregulation) was blocked when mice received an 
injection of an anti-TNFα blocking antibody. Furthermore, local blockade of ICAM-1 or MAC-1 
inhibited this crawling response while interstitial migration of the leukocytes and their capacity to enter 
the lymphatic vessels were unaffected. Overall, the local injection of blocking antibodies inhibiting 
neutrophil-lymphatic endothelium luminal interactions resulted in a reduction of neutrophil numbers 
infiltrating the LNs, highlighting potential and effective targets to manipulate the role of neutrophils in 
adaptive immune responses in vivo. 
In conclusion, the data presented here provide an insight into the mechanisms underlying neutrophil 
trafficking into and within lymphatic vessels of inflamed tissues. Specifically, we have unravelled a 
predominant role for endogenous TNFα in orchestrating both CCR7-dependent migration of neutrophils 
into afferent lymphatics and ICAM-1-dependent crawling on the luminal surface of lymphatic 
endothelium during the acute phase of the inflammatory response as induced by antigen sensitisation. 
Overall, our findings identify TNFα as a new molecular regulator of neutrophil migration into the 
lymphatic system that may provide the opportunity for the development of improved immunisation 










Recombinant murine TNFα purchased from R&D Systems, Complete Freund’s Adjuvant from 
AMSbio, Ovalbumin and AMD3100 from Sigma; and chick Collagen II from MB Biosciences. The 
following primary antibodies were used for immunofluorescence labelling for confocal imaging and 
confocal IVM: rat anti–mouse LYVE-1 mAb (clone ALY7; eBioscience); non-blocking rat anti–mouse 
PECAM-1 Ab (clone C390, eBioscience); rat anti–mouse ICAM-1 mAb (clone YN1/1.4.7; purified and 
Alexa 488-conjugated, eBioscience); rat anti–mouse MAC-1 mAb (clone M1/70, BioLegend); 
monoclonal rat anti–mouse MRP14 mAb (clone 2B10; a gift from N. Hogg, Cancer Research UK, 
London, UK); rat anti-mouse Ly6G mAb (clone 1A8, Alexa 647-conjugated, Biolegend); rat anti-
mouse CXCR4 mAb (clone 2B11, PE-conjugated, eBioscience), rat anti-mouse/human High 
Endothelial Venule mAb (MECA-79, Alexa 488-conjugated eBioscience), rat anti-mouse CCR7 mAb 
(clone 4B12, Alexa 488- or biotin-conjugated, eBioscience); rat anti-mouse CD45.2 mAb (clone 104, 
PE/Cy7-conjugated, Biolegend), rat anti-mouse TNFα mAb (clone MP6-XT22, Biolegend), anti-mouse 
CCL21, anti-mouse CXCL1 and anti-mouse CXCL12 mAbs (R&D systems), polyclonal goat anti–
mouse TNFR p55  and p75 Abs (R&D Systems) . The following purified antibodies were used as 
isotype-matched control Abs: rat IgG1, IgG2a and IgG2b (Biolegend). Unlabelled antibodies were 
directly conjugated Alexa Fluor dyes using Molecular Probes Alexa Fluor Monoclonal Antibody 
Labeling kit (Invitrogen) for confocal microscopy analysis. 
 
Animals 
Male mice (8-12 weeks) wild-type (WT, Charles Rivers), CCR7 knockout (CCR7KO, JAXLab), LysM-
EGFP ki (LysM-GFP), LysM-EGFP ki × CCR7 ko (LysM-GFP/CCR7KO) (all on a C57BL/6 
background) and TNFRdb knockout (TNF receptors p55 and p75 double knockout mice, JAXLab) mice 
were used for these experiments. Only heterozygote LysM-GFP animals exhibiting fluorescent myeloid 
cells (neutrophils comprising the highest percentage of GFP high cells) were used for this study with 
the permission of T. Graf (Albert Einstein College of Medicine, Bronx, NY). These animals were 
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provided by M. Sperandio (Ludwig Maximilians University, Munich, Germany) and bred in-house in 
individually ventilated cages; and facilities were regularly monitored for health status and infections. 
Chimeric mice deficient in leukocyte TNFR p55 and p75 or were generated by lethal irradiation of 
C57BL/6 WT mice (5.5 Gy twice, 4 h apart) and injection of bone marrow cells (1.5 × 106 cells/recipient 
i.v.) from TNFRdbKO mice. C57BL/6 WT littermates receiving WT bone marrow were used as 
controls. The phenotype of blood circulating neutrophils in chimeric animals was then assess by flow 
cytometry (Figure S4). Similar protocol was used for the generation of chimeric animals exhibiting 
CCR7KO leukocytes following the injection of donor LysM-GFP/CCR7KO bone marrow cells into 
lethally irradiated WT recipient animals. Depletion of tissue-resident macrophages of the cremaster 
muscles was achieved by 3 consecutive i.s. injections of clodronate liposomes (Encapsula 
NanoSciences LLC; 250µg/mouse, 20hrs apart) prior to the induction of inflammation. With this 
protocol we achieved ~85.9% of depletion as quantified by flow cytometry (data not shown). All 
experiments were approved by the local biological service unit Ethical Committee at Queen Mary 
University of London and carried out under the Home Office Project Licenses (70/7884 & 70/8264) 
according to the guidelines of the United Kingdom Animals Scientific Procedures Act (1986). At the 
end of all in vivo experiments, animals were humanely killed by cervical dislocation in accordance with 
UK Home Office regulations. 
 
Induction of cremaster inflammation 
WT C57BL/6 male mice (8-12 weeks old) were sedated with 30µl intramuscular (i.m.) injection of 
ketamine (100mg/kg) and xylazine (10mg/kg) in saline before their cremaster muscles were stimulated 
via intrascrotal (i.s.) injection of TNFα (300ng/400µl PBS) or an emulsion of CFA (200µg/300µl per 
mouse) and ovalbumin or chick collagen II (200µg per mouse). Control mice received 300-400μl of 
PBS via i.s. injection. In some experiments, mice were pre-treated locally with the CXCR4 inhibitor 
AMD3100 or vehicle (10mg/kg, 250µl, i.s. 4hrs post-inflammation) prior to the visualisation of the 
inflammatory response. Several time points following TNFα/CFA+Ag stimulation were investigated 
over the course of 48hrs. 
 




Intravital confocal microscopyLysM-GFP mice were stimulated with i.s. injection of either TNFα or 
CFA+Ag and the inflammatory response was allowed to develop for 4 (TNFα) to 6hrs (CFA+Ag) before 
visualisation of the response by intravital confocal microscopy. In some experiments, CFA+Ag-
stimulated animals were pre-treated with a local (i.s.) injection of the following blocking antibodies 90 
to 120min before surgery: anti- TNFα or rat IgG1κ isotype control mAbs (50µg/mouse), anti-ICAM-
1/anti-MAC-1 mAbs or rat IgG2b isotype control mAbs (10µg/mouse) along with non-blocking dose 
of an anti-LYVE-1 mAb (2µg/mouse, Alexa555 conjugated) and/or a non-blocking anti-PECAM-1 
mAb (2µg/mouse, Alexa647 conjugated) to label the lymphatic and blood vasculatures, respectively. 
Thirty minutes before surgery, mice were sedated with i.p. injection of ketamine (100mg/kg) and 
xylazine (10mg/kg). Following surgery, cremaster muscles were imaged with a Leica SP5 or SP8 
confocal microscope 58 for another 90min with a superfusion of warm Tyrode’s solution. Images were 
acquired every minute with the use of a 20× water-dipping objective (NA:1.0) with sequential scanning 
of different channels at a resolution of 1024×700 pixels in the x×y plane and 0.7µm steps in z-direction. 
4D confocal image sequences were then analysed offline using IMARIS software (Bitplane, 
Switzerland), enabling the dynamic interaction of neutrophils with lymphatic vessels be observed, 
tracked, and quantified as previously described 34. 
Confocal microscopy on fixed tissue 
Following immunostaining, the cremaster muscles were imaged with a Leica SP8 confocal microscope 
with the use of a 20× water-dipping objective (NA:1.0). Images of post-capillary venules and lymphatic 
vessels (at least 6 vessels per tissue) were attained with the use of sequential scanning of different 
channels at every 0.52µm of tissue depth at a resolution of 1024×470 and 1024×800 pixels in the x×y 
plane, respectively. This resolution of pixels correspond to a voxel size of 0.24×0.24×0.5µm in x×y×z. 
Post-capillary venules and lymphatic vessels were imaged at a zoom factor of ×1.9 and ×1.2, 
respectively. Quantification of neutrophil transmigration and intravasation into lymphatic vessels were 
analysed with the 3D-reconstructing image processing software IMARIS. Transmigrated neutrophils 
were defined as the number of neutrophils present in the extravascular tissue across a 300µm blood 
vessel segment and within 50μm from each side of the venule of interest. Data was expressed as the 
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number of neutrophils per volume of tissue. Intravasated neutrophils were defined as the number of 
neutrophils present inside the lymphatic vessels and data were expressed as the number of neutrophils 
per given volume of lymphatic vessel quantified by IMARIS Software by creating an isosurface 
representing exclusively the LYVE-1 positive lymphatic endothelium. To assess ICAM-1 and CCL21 
expression on lymphatic vessels, specific primary antibodies or control isotype-matched antibodies 
were injected i.s. 1hr prior to the exteriorisation of the cremaster muscles; and following the analysis of 
tissues by confocal microscopy, the mean fluorescence intensity (MFI) of the staining for molecule of 
interest was determined using IMARIS software on the LYVE-1 isofurface as determined by IMARIS 
software. Intensity profiles for CCL21 expression along a certain distance (10µm away from or 100µm 
within the lymphatic vessel) was performed using Image J. For the LNs, halved samples were imaged 
with a Leica SP8 confocal microscope with the use of a 10× water-dipping objective (NA:1.0). Images 
(12 images per pair of LNs per mouse) were obtained with the use of sequential scanning of different 
channels at every 5.8µm of tissue depth at a resolution of 1024×1024 pixels in the x×y plane, 
corresponding to a voxel size of 0.91×0.91×5.8µm in x×y×z. Quantification of neutrophil recruitment 
into the inguinal LNs were analysed with the 3D-reconstructing image processing software IMARIS. 
Recruited neutrophils were defined as the number of neutrophils per volume of tissue, excluding (unless 
specified) the blood circulating neutrophils present in HEVs.  
 
Flow cytometry  
Whole blood and single cell suspension from (collagenase+DNAse)-digested cremaster muscles and 
LNs of CFA+Ag-stimulated WT and CCR7KO animals, were fluorescently labelled with conjugated 
antibodies against CD45.2, Ly6G, CD11c, CD3ε, CCR7, CXCR4, TNFRp55, TNFRp75 or the 
appropriate isotype control antibodies (0.2–2 µg/ml, various fluorochromes) and DAPI (for viability) 
for at least 1hr at 4°C. Viable leukocytes were identified by FSC and SSC characteristics and CD45.2 
positive and DAPI negative staining. Neutrophils were identified based on Ly6G high staining. In some 
experiments, blood leukocytes where incubated at 37C in RPMI medium (supplemented with 10% FCS 
and 2mM of L-Glutamin) with various concentration of TNFα (1, 10 or 100 ng/ml) for 4 hrs in the 
presence of 50 µM of Nystatin (Sigma, an endocytosis inhibitor) prior to immunofluorescence staining. 
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Samples were analysed using a BD LSR-Fortessa (BD Biosciences) and FlowJo analysis software 
(Treestar). In some studies the intracellular expression of CCR7 was performed using the 
Cytofix/Cytoperm kit (BD) according to the manufacturer’s recommendations. 
 
ELISA 
Snap frozen cremaster tissues from WT mice stimulated with CFA+Ag were transferred into screw-top 
tubes containing homogenising beads along with 500µl homogenising buffer (1% Triton™ X-100, 1% 
protease inhibitor, PBS) prior to being placed in a high-throughput tissue homogeniser, Precellys® 24 
(Precellys, Derbyshire, UK), for 3 cycles of 20s homogenisation at 6500 r.p.m with 40s rest between 
each cycle. Homogenised samples were then frozen at -80°C for 1h before being thawed and centrifuged 
for 5min at 10,000g using a tabletop centrifuge.  The supernatant was taken and used to quantify the 
release of TNFα, GM-CSF, IL-17, CCL21, CCL19 and CXCL12 by ELISA (eBioscience, Hatfield, UK 
or R&D Systems, UK) according to the manufacturer's protocol. 
 
Statistical analysis 
Data are presented as mean±S.E.M per mouse. Significant differences between multiple groups were 
identified by one-way analysis of variance (ANOVA), followed by Newman-Keuls Multiple 
Comparison Test or a two-way analysis of variance (ANOVA) followed by Holm-Sidak Multiple 
Comparison Test when at least 2 different independent variables are being compared. Whenever two 
groups were compared Student’s t test was used. P-values < 0.05 were considered significant. 
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Dynamics of neutrophil migration into cremaster muscle lymphatics upon TNFα-stimulation. 
The dynamics of neutrophil migration into the tissue and lymphatic vessels was analysed by intravital 
confocal microscopy in TNFα-stimulated mouse cremaster muscles. (a) Representative 3D-
reconstructed still image (2µm cross-section) from a LysM-GFP×αSMA-CherryRFP mouse [exhibiting 
both endogenous GFP-fluorescent neutrophils (green) and RFP-fluorescent pericytes/smooth muscle 
cells (red) and immunostained with a non-blocking anti-PECAM-1 mAb (blue)] cremaster tissue 
showing a neutrophil within the lymphatic vessel (yellow arrow) post TNFα-stimulation. (b) Time-
course of neutrophil extravasation in TNFα-stimulated cremaster muscles. (c) Time-course of 
neutrophil migration into lymphatic vessels upon TNFα-stimulation. (d) Total neutrophil-infiltrate in 
dLNs upon TNFα-stimulation. (e) Representative 3D-reconstructed still image of a post-capillary 
venule and an adjacent lymphatic vessel from a LysM-GFP mouse (immunostained with non-blocking 
anti-PECAM-1 mAb (blue)]. The right panel images illustrate a time-lapse series of 2μm-thick cross-
sections along the z-plane (dotted-yellow arrow) showing the migration of two neutrophils (Cell-1 & 
Cell-2) into the lymphatic vessel. (f) Representative 3D-reconstructed still image of a lymphatic vessel 
from a TNFα-stimulated cremaster tissue of a LysM-GFP mouse and immunostained with an anti-
LYVE-1 mAb (red) in vivo. Neutrophil crawling path (colour-coded line) and directionality (white 
arrow) is shown on the image. The bottom panel images are a series of high magnification cross-sections 
of the main image at indicated time-points illustrating the continuous attachment of the neutrophil to 
the lymphatic endothelium. (g) Percentage of neutrophils crawling in the afferent direction (flow) or in 
the opposite direction (anti-flow). Speed (h), directionality (i) and straightness (j) of neutrophils 
crawling in the afferent (flow) or opposite direction (anti-flow) of the cremaster lymphatic vessels. 
Data are expressed as mean ± SEM from 5-12 animals per group (at least 5 independent experiments). 
For the crawling parameter analysis, a total of 63 cells were quantified from 8 mice. Statistically 
significant differences between stimulated and unstimulated treatment groups are indicated by asterisks: 
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*, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. Significant differences between responses 
at different time points are indicated by hash symbols: #, P < 0.05; ####, P < 0.0001. Bar=10μm. 
 
Figure 2.  
Neutrophil rapidly migrates into lymphatic system of the cremaster muscle during antigen 
sensitisation in vivo. 
Neutrophil migration into the lymphatic system was induced in WT animals following antigen 
sensitisation with complete Freund’s adjuvant (CFA+Ag). (a) Time course of neutrophil migration into 
draining LNs (inguinal) or non-draining LNs (axillary) of mice injected intradermally with CFA+Ag 
and as analysed by flow cytometry. (b) Time course of CFA+Ag-induced neutrophil extravasation in 
mice injected intra-scrotally with CFA+Ag as visualised by confocal microscopy. (c) Time course of 
CFA+Ag-induced neutrophil intravasation into the cremaster lymphatic vessels of WT mice as 
visualised by confocal microscopy. (d) Time course of neutrophil migration into draining and non-
draining LNs in mice as analysed by flow cytometry. (e) Quantification of neutrophil localisation in the 
dLNs of mice stimulated intra-scrotally with CFA (8 or 16hrs) or with PBS (control), and as analysed 
by confocal microscopy. Data are represented as percentages of neutrophils present in the HEV, LYVE-
1+ vessels and in the stroma of the LNs. 
Data are expressed as mean±SEM of N = 5-12 animals (~10 images per cremasters for confocal 
microscopy) per group from at least 5-10 experiments. Statistically significant differences between 
stimulated and control groups or between WT and TNFRdbKO mice are indicated by asterisks: *, P < 
0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. Significant differences between other groups are 
indicated by hash symbols: ##, P < 0.01; ####, P < 0.0001. 
 
Figure 3: 
TNFα instruct the neutrophils to migrate into the lymphatic system upon antigen sensitisation. 
Neutrophil migration into the lymphatic system of the cremaster muscle following antigen sensitisation 
with complete Freund’s adjuvant (CFA+Ag) was induced in WT and TNFRdbKO animals as well as in 
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chimeric animals exhibiting neutrophils deficient in TNFRs. (a) Time course of TNFα release in the 
cremaster muscles of WT mice following intra-scrotal injection of CFA+Ag and as quantified by 
ELISA. (b) TNFα release in mice subjected to clodronate liposome-induced macrophage depletion. (c) 
Number of extravasated neutrophils in cremaster muscles of WT and TNFRdbKO mice at 16hrs post-
CFA+Ag-stimulation as quantified by confocal microscopy. (d) Number of neutrophils within 
cremaster lymphatic vessels of WT and TNFRdbKO mice at 16hrs post-CFA+Ag-stimulation as 
quantified by confocal microscopy. (e) Percentage of neutrophils in dLNs of WT and TNFRdbKO mice 
at 16hrs post-CFA+Ag-stimulation as quantified by flow cytometry. (f) Number of extravasated 
neutrophils in cremaster muscles at 16hrs post-CFA+Ag-stimulation from chimeric animals receiving 
bone marrow transplant from WT or TNFRdbKO donor mice and as quantified by confocal microscopy. 
(g) Number of neutrophils within cremaster lymphatic vessels at 16hrs post-CFA+Ag-stimulation from 
chimeric animals receiving bone marrow transplant from WT or TNFRdbKO donor mice and as 
quantified by confocal microscopy. (h) Number of neutrophils found in the dLNs of chimeric animals 
receiving bone marrow transplant from WT or TNFRdbKO donor mice as quantified by confocal 
microscopy 16hrs post-CFA+Ag-stimulation. 
Data are expressed as mean±SEM of N = 5-12 animals per group from at least 5-10 experiments. 
Statistically significant differences between stimulated and control groups or between WT and 
TNFRdbKO mice are indicated by asterisks: *, P < 0.05; **, P < 0.01; ****, P < 0.0001. 
 
Figure 4. 
TNFα promotes CCR7-dependent migration of neutrophils into lymphatic vessels in vivo. 
(a) Analysis by flow cytometry of CCR7 expression (intracellular and cell-surface) on neutrophils 
isolated from the blood circulation, CFA+Ag-stimulated-cremaster muscles and dLNs of WT and 
CCR7KO animals. (b) CCR7 surface expression on tissue-infiltrated neutrophils from WT and 
TNFRdbKO mice subjected to CFA+Ag-induced inflammation. (c-e) WT and CCR7KO mice were 
subjected to TNFα-induced cremaster muscle inflammation and neutrophil responses in the tissue and 
dLNs was assessed by confocal microscopy 16hrs post-inflammation. (c) Number of extravasated 
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neutrophils in of WT and CCR7KO mice. (d) Number of intravasated neutrophils in lymphatic vessels 
of cremaster muscles from WT and CCR7KO mice. (e) Neutrophil number in the cremaster dLNs of 
WT and CCR7KO animals. (f-k) WT, CCR7KO mice or CCR7KO-neutrophil chimeric animals were 
subjected to antigen sensitisation (CFA+Ag) and neutrophil responses in the cremaster muscle and 
dLNs (16hrs post-inflammation) was assessed by confocal microscopy. (f) Number of extravasated 
neutrophils in inflamed cremaster muscles of WT and CCR7KO mice. (g) Number of intravasated 
neutrophils in cremaster lymphatic vessels of WT and CCR7KO mice. (h) Neutrophil number in the 
cremaster dLNs of WT and CCR7KO mice. (i) Number of neutrophils recruited to the cremaster 
muscles from lethally irradiated WT animals receiving bone marrow transplant from either WT or 
CCR7KO donor mice. (j) Number of neutrophils within cremaster lymphatic vessels post-CFA+Ag-
stimulation from lethally irradiated WT animals receiving bone marrow transplant from either WT or 
CCR7KO donor mice. (k) Neutrophil number in the cremaster dLNs from lethally irradiated WT 
animals receiving bone marrow transplant from either WT or CCR7KO donor mice. 
Data are expressed as mean±SEM of N = 7-12 animals per group (from at least 5 independent 
experiments). Statistically significant differences between stimulated/specific mAb and unstimulated 
treatment/isotype control groups are indicated by asterisks: *, P < 0.05; **, P < 0.01; ***, P < 0.001; 
****, P < 0.0001. Significant differences between responses in WT vs. CCR7KO animals (or between 




TNFα controls the crawling of neutrophils into the lymphatic vessels in vivo. 
The effect of anti- TNFα blocking mAb on neutrophil crawling along the luminal side of the lymphatic 
endothelium was analysed by intravital confocal microscopy (IVM) using LysM-GFP mice subjected 
to CFA+Ag-induced cremaster inflammation and immunostained in vivo with a non-blocking dose of 
Alexa555-conjugated anti-LYVE-1 mAb. Isotype control or anti- TNFα blocking mAbs were injected 
i.s. 4hrs post-inflammation. (a) The pictures are representative still images at one time point of the IVM 
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recording showing lymphatic-infiltrated neutrophils (green) and their associated crawling path (time-
coloured mapped line) and/or directionality (arrow) as analysed by IMARIS software (LYVE-1 with 
an opacity filter of 5% to see the intravasated leukocytes) from CTL (left panel) or anti- TNFα (right 
panel) mAb-treated groups. (b) The graphs show the crawling paths of lymphatic-infiltrated neutrophils 
in the X & Y planes of the lymphatic vessels from CTL mAb (left panel) and anti- TNFα mAb (right 
panel) treated groups. (c) Quantification (in percentage) of neutrophils crawling in the afferent (flow) 
or opposite direction (anti-flow) of the lymphatic vessel. Mean speed (d), directionality (e) and 
straightness (f) of neutrophils crawling in CTL mAb and anti- TNFα treated groups.  
A total of 280 cells were analysed. Results are expressed as mean±SEM of N = 4–9 mice (each mouse 
representing one independent experiment). Significant differences between flow and anti-flow crawling 
cells are indicated by *, P < 0.05; ****, P < 0.0001. Significant differences between the CTL and anti– 
TNFα mAb treated groups are indicated by hash symbols: ##, P < 0.01; ###, P < 0.001; ####, P < 
0.0001. Bar = 20 µm. 
 
Figure 6: 
TNFα controls ICAM-1 expression on lymphatic endothelial cells in vivo. 
Cremaster muscles of WT mice were stimulated with TNFα or CFA+Ag (6-8 hrs) and immunostained 
with Alexa555-conjugated anti-LYVE-1 and Alexa488-conjugated anti-ICAM-1 (or an isotype control) 
mAbs to label the lymphatic vasculature and ICAM-1, respectively. (a) The pictures are representative 
confocal images of cremaster lymphatic vessels showing the expression of ICAM-1 on selected 
lymphatic vessels from a PBS-treated control (left panels), TNFα-stimulated (middle panels) and 
CFA+Ag-stimulated (right panels) animals. (b) ICAM-1 expression (mean fluorescent intensity or 
MFI) on vessels from PBS-treated control, TNFα-stimulated and CFA+Ag-stimulated cremaster 
muscles as quantified by IMARIS software. (c) ICAM-1 expression on lymphatic vessels of CFA+Ag-
stimulated cremaster muscles from animals pre-treated with an anti- TNFα blocking mAb or isotype 
CTL mAb injected 4hrs post-inflammation. Data are expressed as mean±SEM of N = 8-12 
vessels/animals from 4 animals per group (3 independent experiments). Statistically significant 
differences between the staining of isotype control and anti-ICAM-1 Abs treated groups are indicated 
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by asterisks: *, P < 0.05; ****, P < 0.0001. Significant differences between unstimulated and inflamed 
groups are indicated by hash symbols: ##, P < 0.01; ####, P < 0.0001. Bar = 50µm.Results are expressed 
as mean±SEM of N = 4–9 mice (1-2 vessels analysed/mouse for intravital confocal microscopy, each 
mice is a single experiment). Significant differences between blocking antibodies treated and control 
groups are indicated by *, P < 0.05; ***, P < 0.001; ****, P < 0.0001. Significant differences between 
other groups are indicated by # (P < 0.05). Bar = 30µm. 
 
Figure 7: 
Neutrophil crawling along the lymphatic endothelium is ICAM-1/MAC-1 dependent. 
LysM-GFP mice were subjected to CFA+Ag-induced cremaster inflammation for 6hrs. Mice also 
received at 4.5hrs post inflammation an i.s. injection of non-blocking dose of Alexa555-conjugated 
anti-LYVE-1 (red) and Alexa647-conjugated anti-PECAM-1 mAbs (not shown on the image) for the 
visualisation of both the lymphatic and blood vasculatures. Ninety minutes later, tissues were 
exteriorised to perform time-lapse recordings of the neutrophil responses for 2hrs by intravital confocal 
microscopy. The effect of blocking antibodies against ICAM-1 and MAC-1 (injected locally 90min 
before recordings) on neutrophil migration paths in the interstitium and lymphatic vessels was 
investigated and analysed using IMARIS software. (a) The pictures are representative 3D still images 
showing neutrophils (green) within the lymphatic vessels (red) and their respective crawling path (time-
coloured mapped line) and directionality (arrow) from mice pre-treated with an isotypic control (CTL, 
top panel), anti-ICAM-1 (middle panel) or anti-MAC-1 (bottom panel) mAbs. (b) The graphs show the 
crawling paths of neutrophils in the X & Y planes of the lymphatic vessels from CTL Ab, anti-ICAM-
1 and anti-MAC-1 mAbs treated groups. (c-e) The effect of anti–ICAM-1 and anti-MAC-1 blocking 
antibodies on neutrophil migration parameters (i.e. interstitial and intraluminal crawling) was quantified 
and compared to the responses obtained with an isotype CTL mAb. The three graphs show the mean 
speed (c), directionality (d) and straightness (e) of neutrophils crawling. A total of 280 cells were 
analysed. The numbers of neutrophils in the interstitial tissue (f) and inside the lymphatic vessels (g) 
were quantify by confocal microscopy. (h) Neutrophil infiltration of cremaster dLNs was also 
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quantified at the end of the experiment.Results are expressed as mean±SEM of N = 4–9 mice (1-2 
vessels analysed/mouse for intravital confocal microscopy, each mice is a single experiment). 
Significant differences between blocking antibodies treated and control groups are indicated by *, P < 
0.05; ***, P < 0.001; ****, P < 0.0001. Significant differences between other groups are indicated by 
# (P < 0.05). Bar = 30µm. 
 
Figure 8: 
Schematic diagram illustrating the dual mechanisms of action of TNFα leading to the trafficking 
of neutrophils into and within the lymphatic vasculature upon acute inflammation in vivo. 
During the acute inflammatory response of the tissue following antigen sensitisation, endogenous TNFα 
release primed the freshly recruited neutrophils. This cytokine allow these leukocytes to be attracted to 
the lymphatic vessels in a CCR7 dependent manner (intravasation). Furthermore, endogenous TNFα 
also stimulate the lymphatic endothelium to express ICAM-1 on their surface, allowing the neutrophils 
present in the lymphatic vessels to adhere and crawl along the luminal side in the correct direction 



















T = 0 min T = 39 min T = 29 min T = 19 min T = 9 min T = 49 min T = 59 min 
T = 0 min 
T = 
9 min 
T = 19 min 
T = 39 min 
T = 29 min 
T = 49 min 
T = 59 min 
Figure 1 




























T = 3 min 
T = 5 min 
T = 0 min 
(BV) (LV) 
Cell 1 
T = 14 min 
T = 16 min 










Figure 2   













             
 
  
Migration into the tissue Migration into tissue lymphatic 
vessels 
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Neutrophil breaching of the lymphatic endothelium in a TNF-stimulated tissue (Figure 1e). The video 
shows a cremaster lymphatic vessel of a LysM-GFP mouse (exhibiting GFP-labelled leukocytes 
(green), immunostained in vivo for ECs with Alexa647-labelled anti-PECAM-1 mAb (blue) and 
stimulated with TNF (300ng/mouse i.s.). The video shows the migration of a neutrophil (recorded from 
4hrs after injection of the cytokine) into the lumen of the lymphatic vessel. Images were captured every 
minute for 90min. Still images are shown in Fig. 1e. 
 
Video 2 
Neutrophil breaching of the lymphatic endothelium in a TNF-stimulated (300ng/mouse i.s.) cremaster 
lymphatic vessel of a LysM-GFP mouse (exhibiting GFP-labelled leukocytes (green), and 
immunostained in vivo for LECs with non-blocking dose of an Alexa555-labelled anti-LYVE-1 mAb 
(red). The video shows the migration of a neutrophil (in green and isolated from the rest of the 
inflammatory response by creating an isosurface on it using IMARIS software for clarity of the image) 
into the lumen of the lymphatic vessel (recorded from 2hrs after injection of the cytokine). Images were 
captured every minute for 90min. 
 
Video 3 
Intraluminal neutrophil crawling along the lumen of the lymphatic endothelium (Figure 1f). The video 
captures the intraluminal crawling of neutrophils (in green) along the lymphatic endothelial cell wall in 
a TNF-stimulated cremaster of a LysM-GFP mouse (exhibiting GFP-labelled leukocytes (green). 
Lymphatic vessels were immunostained in vivo with Alexa555-labelled anti–LYVE-1 mAb (red) and 
Alexa647-labelled anti-PECAM-1 mAb (blue). Images were captured from 4hrs post-inflammation at 
one stack per minute for a duration of 90 min. Still images of this video are shown in Fig. 1f. 
 
Video 4 
Intraluminal neutrophil crawling with isotype control (IgG1, κ) mAb (Figure 5a). The video captures 
the intraluminal crawling of several neutrophils (in green and isolated from the rest of the inflammatory 
response by creating an isosurface on them using IMARIS software for clarity of the image) along the 
lymphatic endothelial cell wall in a CFA+Ag-stimulated cremaster of a LysM-GFP mouse (exhibiting 
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GFP-labelled leukocytes (green) immunostained in vivo with Alexa555–labelled anti–LYVE-1 mAb 
(red) and Alexa647-labelled anti-PECAM-1 mAb (blue), in the presence of an IgG1, κ isotype control 
(50μg/mouse). The IgG1, κ isotype control mAb was injected i.s. 4hrs post inflammation before 
exteriorisation of the cremaster muscles to perform intravital confocal microscopy 2hrs later. At the end 
of the sequence, the track followed by the neutrophils during their crawling on the luminal side of the 
lymphatic endothelium is shown, alongside the displacement (arrow). Images were captured at one 
stack per minute for a duration of 90min. A still image of this is shown in Fig. 5a.  
 
Video 5 
Intraluminal neutrophil crawling with anti-TNF blocking mAb (Figure 5a). The video captures the 
intraluminal crawling of several neutrophils (in green and isolated from the rest of the inflammatory 
response by creating an isosurface on them using IMARIS software for clarity of the image) along the 
lymphatic endothelial cell wall in a CFA+Ag-stimulated cremaster of a LysM-GFP mouse (exhibiting 
GFP-labelled leukocytes (green) and immunostained in vivo with Alexa555–labelled anti–LYVE-1 
mAb (red) and Alexa647-labelled anti-PECAM-1 mAb (blue), in the presence of an anti-TNF blocking 
Ab (50μg/mouse). The anti-TNF blocking Ab was injected i.s. 4hrs post-inflammation before 
exteriorisation of the cremaster muscles to perform intravital confocal microscopy 2hrs later. At the end 
of the sequence, the track followed by the neutrophils during their crawling on the luminal side of the 
lymphatic endothelium is shown, alongside the displacement (arrow). Images were captured at one 
stack per minute for a duration of 90min. A still image of this is shown in Fig. 5a.  
 
Video 6 
Intraluminal neutrophil crawling with isotype control (IgG2b, κ) mAb (Figure 7a). The video captures 
the intraluminal crawling of several neutrophils (in green and isolated from the rest of the inflammatory 
response by creating an isosurface on them using IMARIS software for clarity of the image) along the 
lymphatic endothelial cell wall in a CFA+Ag-stimulated cremaster of a LysM-GFP mouse (exhibiting 
GFP-labelled leukocytes (green) immunostained in vivo with Alexa555–labelled anti–LYVE-1 mAb 
(red) and Alexa647-labelled anti-PECAM-1 mAb (blue), in the presence of an IgG2b, κ isotype control 
(10μg/mouse). Antibodies were injected i.s. 90min before exteriorisation of the cremaster muscles and 
visualisation by intravital confocal microscopy from 6hrs post inflammation. At the end of the sequence, 
the track followed by the neutrophils during their crawling on the luminal side of the lymphatic 
endothelium is shown, alongside the displacement (arrow). Images were captured at one stack per 





Intraluminal neutrophil crawling with anti-ICAM-1 blocking mAb (Figure 7a). The video captures the 
intraluminal crawling of several neutrophils (in green and isolated from the rest of the inflammatory 
response by creating an isosurface on them using IMARIS software for clarity of the image) along the 
lymphatic endothelial cell wall in a CFA+Ag-stimulated cremaster of a LysM-GFP mouse (exhibiting 
GFP-labelled leukocytes (green) immunostained in vivo with Alexa555–labelled anti–LYVE-1 mAb 
(red) and Alexa647-labelled anti-PECAM-1 mAb (blue), in the presence of an anti-ICAM-1 blocking 
mAb (10μg/mouse). Antibodies were injected i.s. 90min before exteriorisation of the cremaster muscles 
and visualisation by intravital confocal microscopy. At the end of the sequence, the track followed by 
the neutrophils during their crawling on the luminal side of the lymphatic endothelium is shown, 
alongside the displacement (arrow). Images were captured at one stack per minute for a duration of 
90min. A still image of this is shown in Fig. 7a.  
 
Video 8 
Intraluminal neutrophil crawling with anti-MAC-1 blocking mAb (Figure 7a). The video captures the 
intraluminal crawling of several neutrophils (in green and isolated from the rest of the inflammatory 
response by creating an isosurface on them using IMARIS software for clarity of the image) along the 
lymphatic endothelial cell wall in a CFA+Ag-stimulated cremaster of a LysM-GFP mouse (exhibiting 
GFP-labelled leukocytes (green) immunostained in vivo with Alexa555–labelled anti–LYVE-1 mAb 
(red) and Alexa647-labelled anti-PECAM-1 mAb (blue), in the presence of an anti-MAC-1 blocking 
mAb (10μg/mouse). Antibodies were injected i.s. 90min before exteriorisation of the cremaster muscles 
and visualisation by intravital confocal microscopy. At the end of the sequence, the track followed by 
the neutrophils during their crawling on the luminal side of the lymphatic endothelium is shown, 
alongside the displacement (arrow). Images were captured at one stack per minute for a duration of 






































Figure S1: Lymphatic architecture of the cremasteric tissue 
(a) Representative 3D-reconstructed confocal image of a whole-mount fixed cremaster muscle of a 
C57BL/6 WT animal and immunostained with antibodies against LYVE-1 (Alexa555-conjugated, red), 
PECAM-1 (Alexa488-conjugated, green) and MRP14 (Alexa647-conjugated, blue) to visualise the 
lymphatic vessels, the endothelial cell junctions and neutrophils, respectively, showing the presence of 
a fully developed lymphatic vasculature in this tissue with blind-ended lymphatic capillary vessels 
(arrow). (b) Representative confocal image of a fixed cremasteric lymphatic vessel immunostained for 
VE-Cadherin (Alexa555-conjugated, red) and PECAM-1 (Alexa647-conjugated, blue). The inserts on 
the right area show a magnified view of the heterogeneous distribution of the adhesion molecules (with 
VE-cadherin-rich buttons and PECAM-1-rich flaps) expressed by the endothelial cells of the 

















Figure S2: Blood neutrophilia following stimulation of the cremaster muscles with CFA+Ag. 
Percentage of neutrophils with the blood circulation of WT mice subjected to cremaster muscle 
inflammation with CFA+Ag as analysed by flow cytometry. Data are expressed as mean±SEM from 4 
independent experiments. Statistically significant differences between the stimulated and control groups 















Figure S3: neutrophil migration response in the cremaster muscle following stimulation with 
CFA+Ag for 8hrs in WT, TNRdbKO and CCR7KO mice 
WT, TNFRdbKO and CCR7KO mice were subjected to CFA+Ag-induced inflammation of the 
cremaster muscles. Controlled mice were injected with PBS. Eight hours later, the cremaster muscles 
were dissected away, fixed and immunostained for LYVE-1, PECAM-1 and MRP14 to visualise the 
lymphatic vasculatures the endothelial cells junctions and neutrophils, respectively before analysis of 
the neutrophil migration responses by confocal microscopy. (a) Number of extravasated neutrophils in 
the cremaster muscles. (b) Number of neutrophils within the cremaster lymphatic vessels. Data are 
expressed as mean±SEM from n = at least 4 animals per group. Statistically significant difference 
between stimulated and unstimulated animals are indicated by asterisks: **, P< 0.01; ***, P < 0.001; 
****, P < 0.0001. Statistically significant difference between WT and KO animals are indicated by 
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Figure S4: Phenotypic analysis of blood neutrophils from TNFRs chimeric animals 
Blood leukocytes from TNFRdbKO or chimeric animals were immunostained for neutrophils specific 
markers (CD45+ Ly6G+) and their surface expression of TNFR p55 and p75 were analysed by flow 
cytometry. The figure shows representative histograms of the fluorescence intensity for P75 (a) and 
P55 (b) of blood neutrophils from lethally irradiated WT mice and reconstituted with TNFRdbKO 
(TNFRdbKO  WT) or WT (WTWT) bone marrow hematopoietic cells (blue) and compared to the 



































Neither CXCL1:CXCR1/2 nor CXCL12:CXCR4 axes play a significant role in neutrophil 
migration across the lymphatic endothelium during antigen sensitisation.  
WT mice were subjected to CFA+Ag-induced inflammation of the cremaster muscles. Four hours later, 
mice received an i.s. injection of an anti-CXCL1 blocking mAb (or an isotype control mAb) or the 
CXCR4 specific inhibitor AMD3100 (or vehicle as control). At the end of the inflammation period, 
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cremaster muscles were dissected away, fixed and immunostained for LYVE-1, PECAM-1 and MRP14 
to visualise the lymphatic vasculatures the endothelial cells junctions and neutrophils, respectively 
before analysis of the neutrophil migration responses by confocal microscopy. (a) Number of 
extravasated neutrophils in the cremaster muscles of unstimulated and CFA+Ag-stimulated (8hrs) mice 
injected with anti-CXCL1 blocking antibody or isotype control. (b) Number of neutrophils within the 
cremaster lymphatic vessels of unstimulated and CFA+Ag-stimulated (8hrs) mice injected with anti-
CXCL1 blocking antibody or isotype control. (c) Number of neutrophils found in the dLNs of the 
cremastermuscle of unstimulated and CFA+Ag-stimulated (8hrs) mice injected with anti-CXCL1 
blocking antibody or isotype control. (d) Number of extravasated neutrophils in inflamed cremaster 
muscles of unstimulated and CFA+Ag-stimulated (16hrs) mice treated with AMD3100 or vehicle 
control. (e) Number of neutrophils within the cremaster lymphatic vessels of unstimulated and 
CFA+Ag-stimulated (16hrs) mice treated with AMD3100 or vehicle control. (f) Number of neutrophils 
found within the dLNs of unstimulated and CFA+Ag-stimulated (16hrs) mice treated with AMD3100 
or vehicle control. (g) Percentage of neutrophils into the blood circulation as assessed by flow 
cytometry. (h) Surface expression of CXCR4 (RFI) on blood circulating neutrophils as assessed by flow 
cytometry. Data are expressed as mean±SEM from at least 4 independent experiments with n = 5-12 
animals per group. Statistically significant difference between stimulated and unstimulated animals are 















Figure S6: low dose of TNFα induces CCR7 expression on blood neutrophils in vitro. 
Whole blood leukocytes from WT and CCR7KO animals were stimulated in vitro with different doses 
of TNFα for 4hrs in the presence of the endocytic inhibitor, nystatin (50 µM). Expression of CCR7 on 
the surface of neutrophils was then assessed by flow cytometry. Dotted line represent the RFI of the 
isotype control antibody. Data are expressed as mean±SEM from 7 independent experiments (at least 7 
mice per condition). Statistically significant difference specific CCR7 staining and isotope control 
antibody are indicated by asterisks: **, P< 0.01. Data were analysed using a two-way analysis of 
variance (ANOVA), followed by Holm-Sidak's multiple comparisons test. Statistically significant 
difference TNFα-stimulated cells and PBS control group are indicated by dash symbols: #, P< 0.05, ### 
P < 0.001. Statistically significant difference TNFα-stimulated cells and PBS control group are 




Figure S7:  













Figure S7: CXCL12:CXCR4 axis is responsible for the high number of neutrophils found into the 
lymph nodes of CCR7KO mice under steady state condition. 
Neutrophil migration into the lymphatic system of the cremaster muscle following antigen sensitisation 
with complete Freund’s adjuvant (CFA+Ag) was induced in WT and TNFRdbKO animals as well as in 
chimeric animals exhibiting neutrophils deficient for CCR7. (a) Percentage of circulating neutrophils 
in naïve WT and CCR7KO animals, as quantified by flow cytometry. (b) Surface expression of CXCR4 
on circulating neutrophils from WT and CCR7KO animals, as quantified by flow cytometry. (c) 
CXCL12 expression in the LNs of naïve WT and CCR7KO mice, as quantified by ELISA. (d) Number 
of extravasated neutrophils in inflamed cremaster muscles of unstimulated and CFA+Ag-stimulated 
CCR7KO mice treated with AMD3100 or the vehicle. (e) Number of neutrophils within the cremaster 
lymphatic vessels of unstimulated and CFA+Ag-stimulated CCR7KO mice treated with AMD3100 or 
the vehicle. (f) Number of neutrophils found into the dLNs of unstimulated and CFA+Ag-stimulated 
CCR7KO mice treated with AMD3100 or the vehicle. Data are expressed as mean±SEM with 5-12 
animals per group. Statistically significant differences between stimulated and unstimulated treatment 
groups are indicated by asterisks: *, P < 0.05; **, P < 0.01. Significant differences between responses 























Figure S8: CCL21 expression in the tissue. 
WT mice were subjected to CFA+Ag-induced inflammation of the cremaster muscles for 8hrs before 
harvesting the tissues for subsequent analysis for the expression of CCL21. (a) Quantification of CCL21 
generation in the tissue of naïve and stimulated mice by ELISA. (b) WT mice subjected to CFA+Ag-
induced inflammation also received a local (i.s.) injection of the anti-TNFα blocking antibody (or an 
isotype control antibody, 50µg/mouse) before quantifying the expression of CCL21 by ELISA. (c) In 
some experiments, at the end of the inflammatory period (8hrs), tissues were fixed and whole-mount 
immunostained for Lyve-1 and CCL21 (or isotype control antibody) before being analysed by confocal 
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microscopy. The intensity of staining for CCL21 was then quantified within both the lymphatic vessels 
and the interstitial tissue using IMARIS software. (d) A line intensity profile was generated 
perpendicular to the direction of the vessel (10 lines/vessel) from the abluminal surface into the tissue 
(10 µm length) to look at a potential gradient of CCL21 guiding the leukocytes toward lymphatic 
vessels. Data are presented as percentage change from the first pixel of the line. (e) Similarly, a surface 
intensity profile within the lymphatic vessels was generated in the direction of the flow (100 µm length). 
Data are presented as percentage change from the first measured pixels of the surface. Data are 
expressed as mean±SEM from at least with 4 animals per group (with at least 5 vessels per mouse fore 
confocal images). Statistically significant differences for CCL21 staining between the isotype control 
antibody vs. anti-CCL21 Ab (c) and for the intensity profiles from the first pixel to the last pixel 
measured (d & e) are indicated by asterisks: *, P < 0.05; **, P < 0.01; ****, P < 0.0001. Significant 
differences between the interstitial tissue vs. the lymphatic vessels and unstimulated vs. stimulated, are 














Figure S9: IL-17 and GM-CSF release upon antigen stimulation of the cremaster muscle. 
Time course of IL17 (left panel) and GM-CSF (right panel) generated in the cremaster muscles of WT 
mice following intra-scrotal injection of CFA+Ag and as quantified by ELISA. Data are expressed as 
mean±SEM from 6-10 mice (from 4 independent experiments). 
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